A data-based assessment of alternative strategies for identification of potential human cancer hazards

R. Alan Boobis, Samuel Monroe Cohen, G. Nancy Doerrer, M. Sheila Galloway, J. Patrick Haley, C. Gordon Hard, G. Frederick Hess, S. James Macdonald, Stéphane Thibault, C. Douglas Wolf, Jayne Wright

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The two-year cancer bioassay in rodents remains the primary testing strategy for in-life screening of compounds that might pose a potential cancer hazard. Yet experimental evidence shows that cancer is often secondary to a biological precursor effect, the mode of action is sometimes not relevant to humans, and key events leading to cancer in rodents from nongenotoxic agents usually occur well before tumorigenesis and at the same or lower doses than those producing tumors. The International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute (HESI) hypothesized that the signals of importance for human cancer hazard identification can be detected in shorter-term studies. Using the National Toxicology Program (NTP) database, a retrospective analysis was conducted on sixteen chemicals with liver, lung, or kidney tumors in two-year rodent cancer bioassays, and for which short-term data were also available. For nongenotoxic compounds, results showed that cellular changes indicative of a tumorigenic endpoint can be identified for many, but not all, of the chemicals producing tumors in two-year studies after thirteen weeks utilizing conventional endpoints. Additional endpoints are needed to identify some signals not detected with routine evaluation. This effort defined critical questions that should be explored to improve the predictivity of human carcinogenic risk.

Original languageEnglish (US)
Pages (from-to)714-732
Number of pages19
JournalToxicologic Pathology
Volume37
Issue number6
DOIs
StatePublished - Dec 2 2009

Fingerprint

Forensic Anthropology
Tumors
Hazards
Bioassay
Neoplasms
Liver
Rodentia
Screening
Health
Biological Assay
Testing
Environmental Health
Biological Science Disciplines
Toxicology
Carcinogenesis
Databases
Kidney
Lung

Keywords

  • Carcinogenesis
  • Carcinogenicity testing
  • Dna reactivity
  • Immunosuppression
  • Kidney carcinogenesis
  • Liver carcinogenesis
  • Lung carcinogenesis
  • Mode of action
  • Nongenotoxic carcinogens

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Toxicology
  • Cell Biology

Cite this

Boobis, R. A., Cohen, S. M., Doerrer, G. N., Galloway, M. S., Haley, J. P., Hard, C. G., ... Wright, J. (2009). A data-based assessment of alternative strategies for identification of potential human cancer hazards. Toxicologic Pathology, 37(6), 714-732. https://doi.org/10.1177/0192623309343779

A data-based assessment of alternative strategies for identification of potential human cancer hazards. / Boobis, R. Alan; Cohen, Samuel Monroe; Doerrer, G. Nancy; Galloway, M. Sheila; Haley, J. Patrick; Hard, C. Gordon; Hess, G. Frederick; Macdonald, S. James; Thibault, Stéphane; Wolf, C. Douglas; Wright, Jayne.

In: Toxicologic Pathology, Vol. 37, No. 6, 02.12.2009, p. 714-732.

Research output: Contribution to journalArticle

Boobis, RA, Cohen, SM, Doerrer, GN, Galloway, MS, Haley, JP, Hard, CG, Hess, GF, Macdonald, SJ, Thibault, S, Wolf, CD & Wright, J 2009, 'A data-based assessment of alternative strategies for identification of potential human cancer hazards', Toxicologic Pathology, vol. 37, no. 6, pp. 714-732. https://doi.org/10.1177/0192623309343779
Boobis, R. Alan ; Cohen, Samuel Monroe ; Doerrer, G. Nancy ; Galloway, M. Sheila ; Haley, J. Patrick ; Hard, C. Gordon ; Hess, G. Frederick ; Macdonald, S. James ; Thibault, Stéphane ; Wolf, C. Douglas ; Wright, Jayne. / A data-based assessment of alternative strategies for identification of potential human cancer hazards. In: Toxicologic Pathology. 2009 ; Vol. 37, No. 6. pp. 714-732.
@article{991b88b353b847cb89158262872d8539,
title = "A data-based assessment of alternative strategies for identification of potential human cancer hazards",
abstract = "The two-year cancer bioassay in rodents remains the primary testing strategy for in-life screening of compounds that might pose a potential cancer hazard. Yet experimental evidence shows that cancer is often secondary to a biological precursor effect, the mode of action is sometimes not relevant to humans, and key events leading to cancer in rodents from nongenotoxic agents usually occur well before tumorigenesis and at the same or lower doses than those producing tumors. The International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute (HESI) hypothesized that the signals of importance for human cancer hazard identification can be detected in shorter-term studies. Using the National Toxicology Program (NTP) database, a retrospective analysis was conducted on sixteen chemicals with liver, lung, or kidney tumors in two-year rodent cancer bioassays, and for which short-term data were also available. For nongenotoxic compounds, results showed that cellular changes indicative of a tumorigenic endpoint can be identified for many, but not all, of the chemicals producing tumors in two-year studies after thirteen weeks utilizing conventional endpoints. Additional endpoints are needed to identify some signals not detected with routine evaluation. This effort defined critical questions that should be explored to improve the predictivity of human carcinogenic risk.",
keywords = "Carcinogenesis, Carcinogenicity testing, Dna reactivity, Immunosuppression, Kidney carcinogenesis, Liver carcinogenesis, Lung carcinogenesis, Mode of action, Nongenotoxic carcinogens",
author = "Boobis, {R. Alan} and Cohen, {Samuel Monroe} and Doerrer, {G. Nancy} and Galloway, {M. Sheila} and Haley, {J. Patrick} and Hard, {C. Gordon} and Hess, {G. Frederick} and Macdonald, {S. James} and St{\'e}phane Thibault and Wolf, {C. Douglas} and Jayne Wright",
year = "2009",
month = "12",
day = "2",
doi = "10.1177/0192623309343779",
language = "English (US)",
volume = "37",
pages = "714--732",
journal = "Toxicologic Pathology",
issn = "0192-6233",
publisher = "SAGE Publications Inc.",
number = "6",

}

TY - JOUR

T1 - A data-based assessment of alternative strategies for identification of potential human cancer hazards

AU - Boobis, R. Alan

AU - Cohen, Samuel Monroe

AU - Doerrer, G. Nancy

AU - Galloway, M. Sheila

AU - Haley, J. Patrick

AU - Hard, C. Gordon

AU - Hess, G. Frederick

AU - Macdonald, S. James

AU - Thibault, Stéphane

AU - Wolf, C. Douglas

AU - Wright, Jayne

PY - 2009/12/2

Y1 - 2009/12/2

N2 - The two-year cancer bioassay in rodents remains the primary testing strategy for in-life screening of compounds that might pose a potential cancer hazard. Yet experimental evidence shows that cancer is often secondary to a biological precursor effect, the mode of action is sometimes not relevant to humans, and key events leading to cancer in rodents from nongenotoxic agents usually occur well before tumorigenesis and at the same or lower doses than those producing tumors. The International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute (HESI) hypothesized that the signals of importance for human cancer hazard identification can be detected in shorter-term studies. Using the National Toxicology Program (NTP) database, a retrospective analysis was conducted on sixteen chemicals with liver, lung, or kidney tumors in two-year rodent cancer bioassays, and for which short-term data were also available. For nongenotoxic compounds, results showed that cellular changes indicative of a tumorigenic endpoint can be identified for many, but not all, of the chemicals producing tumors in two-year studies after thirteen weeks utilizing conventional endpoints. Additional endpoints are needed to identify some signals not detected with routine evaluation. This effort defined critical questions that should be explored to improve the predictivity of human carcinogenic risk.

AB - The two-year cancer bioassay in rodents remains the primary testing strategy for in-life screening of compounds that might pose a potential cancer hazard. Yet experimental evidence shows that cancer is often secondary to a biological precursor effect, the mode of action is sometimes not relevant to humans, and key events leading to cancer in rodents from nongenotoxic agents usually occur well before tumorigenesis and at the same or lower doses than those producing tumors. The International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute (HESI) hypothesized that the signals of importance for human cancer hazard identification can be detected in shorter-term studies. Using the National Toxicology Program (NTP) database, a retrospective analysis was conducted on sixteen chemicals with liver, lung, or kidney tumors in two-year rodent cancer bioassays, and for which short-term data were also available. For nongenotoxic compounds, results showed that cellular changes indicative of a tumorigenic endpoint can be identified for many, but not all, of the chemicals producing tumors in two-year studies after thirteen weeks utilizing conventional endpoints. Additional endpoints are needed to identify some signals not detected with routine evaluation. This effort defined critical questions that should be explored to improve the predictivity of human carcinogenic risk.

KW - Carcinogenesis

KW - Carcinogenicity testing

KW - Dna reactivity

KW - Immunosuppression

KW - Kidney carcinogenesis

KW - Liver carcinogenesis

KW - Lung carcinogenesis

KW - Mode of action

KW - Nongenotoxic carcinogens

UR - http://www.scopus.com/inward/record.url?scp=70649088692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70649088692&partnerID=8YFLogxK

U2 - 10.1177/0192623309343779

DO - 10.1177/0192623309343779

M3 - Article

VL - 37

SP - 714

EP - 732

JO - Toxicologic Pathology

JF - Toxicologic Pathology

SN - 0192-6233

IS - 6

ER -